Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Overexpression of IL-10 Enhances the Efficacy of Human Umbilical-Cord-Derived Mesenchymal Stromal Cells in E. coli Pneumosepsis.

Jerkic M, Masterson C, Ormesher L, Gagnon S, Goyal S, Rabani R, Otulakowski G, Zhang H, Kavanagh BP, Laffey JG.

J Clin Med. 2019 Jun 13;8(6). pii: E847. doi: 10.3390/jcm8060847.

2.

Extracellular Vesicles from Interferon-γ-primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli-induced Acute Lung Injury in Rats.

Varkouhi AK, Jerkic M, Ormesher L, Gagnon S, Goyal S, Rabani R, Masterson C, Spring C, Chen PZ, Gu FX, Dos Santos CC, Curley GF, Laffey JG.

Anesthesiology. 2019 May;130(5):778-790. doi: 10.1097/ALN.0000000000002655.

PMID:
30870158
3.

Mesenchymal stem cells enhance NOX2-dependent reactive oxygen species production and bacterial killing in macrophages during sepsis.

Rabani R, Volchuk A, Jerkic M, Ormesher L, Garces-Ramirez L, Canton J, Masterson C, Gagnon S, Tatham KC, Marshall J, Grinstein S, Laffey JG, Szaszi K, Curley GF.

Eur Respir J. 2018 Apr 26;51(4). pii: 1702021. doi: 10.1183/13993003.02021-2017. Print 2018 Apr.

PMID:
29519920
4.

Stem Cell-based Therapies for Sepsis.

Keane C, Jerkic M, Laffey JG.

Anesthesiology. 2017 Dec;127(6):1017-1034. doi: 10.1097/ALN.0000000000001882. Review.

PMID:
28872482
5.

The authors reply.

Curley GF, Jerkic M, Hogan G, Masterson C, O'Toole D, Devaney J, Laffey JG.

Crit Care Med. 2017 Jul;45(7):e737-e738. doi: 10.1097/CCM.0000000000002480. No abstract available.

PMID:
28622234
6.

Cryopreserved, Xeno-Free Human Umbilical Cord Mesenchymal Stromal Cells Reduce Lung Injury Severity and Bacterial Burden in Rodent Escherichia coli-Induced Acute Respiratory Distress Syndrome.

Curley GF, Jerkic M, Dixon S, Hogan G, Masterson C, O'Toole D, Devaney J, Laffey JG.

Crit Care Med. 2017 Feb;45(2):e202-e212. doi: 10.1097/CCM.0000000000002073.

PMID:
27861182
7.

Increased endothelial cell permeability in endoglin-deficient cells.

Jerkic M, Letarte M.

FASEB J. 2015 Sep;29(9):3678-88. doi: 10.1096/fj.14-269258. Epub 2015 May 13.

PMID:
25972355
8.

Contribution of oxidative stress to endothelial dysfunction in hereditary hemorrhagic telangiectasia.

Jerkic M, Letarte M.

Front Genet. 2015 Feb 13;6:34. doi: 10.3389/fgene.2015.00034. eCollection 2015.

9.

Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos.

Denbeigh JM, Nixon BA, Lee JJ, Jerkic M, Marsden PA, Letarte M, Puri MC, Foster FS.

Angiogenesis. 2015 Jan;18(1):69-81. doi: 10.1007/s10456-014-9447-0. Epub 2014 Oct 9.

PMID:
25298070
10.

Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis.

Peter MR, Jerkic M, Sotov V, Douda DN, Ardelean DS, Ghamami N, Lakschevitz F, Khan MA, Robertson SJ, Glogauer M, Philpott DJ, Palaniyar N, Letarte M.

Mediators Inflamm. 2014;2014:767185. doi: 10.1155/2014/767185. Epub 2014 Jul 10.

11.

Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis.

Ardelean DS, Yin M, Jerkic M, Peter M, Ngan B, Kerbel RS, Foster FS, Letarte M.

Angiogenesis. 2014 Jul;17(3):641-59. doi: 10.1007/s10456-014-9421-x. Epub 2014 Feb 9.

PMID:
24510304
12.

Mesenchymal stromal cell therapies: potential and pitfalls for ARDS.

Masterson C, Jerkic M, Curley GF, Laffey JG.

Minerva Anestesiol. 2015 Feb;81(2):179-94. Epub 2014 Feb 4. Review.

13.

Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks.

Xu G, Barrios-Rodiles M, Jerkic M, Turinsky AL, Nadon R, Vera S, Voulgaraki D, Wrana JL, Toporsian M, Letarte M.

Mol Cell Proteomics. 2014 Feb;13(2):489-502. doi: 10.1074/mcp.M113.033464. Epub 2013 Dec 7.

14.

Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment.

Ardelean DS, Jerkic M, Yin M, Peter M, Ngan B, Kerbel RS, Foster FS, Letarte M.

Angiogenesis. 2014 Jan;17(1):129-46. doi: 10.1007/s10456-013-9383-4. Epub 2013 Sep 24.

PMID:
24061911
15.

Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability.

Pérez-Gómez E, Jerkic M, Prieto M, Del Castillo G, Martín-Villar E, Letarte M, Bernabeu C, Pérez-Barriocanal F, Quintanilla M, López-Novoa JM.

J Invest Dermatol. 2014 Jan;134(1):247-255. doi: 10.1038/jid.2013.263. Epub 2013 Jun 13.

16.

Oxidative stress contributes to endothelial dysfunction in mouse models of hereditary hemorrhagic telangiectasia.

Jerkic M, Sotov V, Letarte M.

Oxid Med Cell Longev. 2012;2012:686972. doi: 10.1155/2012/686972. Epub 2012 Dec 25.

17.

Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.

Jerkic M, Kabir MG, Davies A, Yu LX, McIntyre BA, Husain NW, Enomoto M, Sotov V, Husain M, Henkelman M, Belik J, Letarte M.

Cardiovasc Res. 2011 Dec 1;92(3):375-84. doi: 10.1093/cvr/cvr232. Epub 2011 Aug 22.

PMID:
21859819
18.

Nitric oxide supplementation in postischemic acute renal failure: normotension versus hypertension.

Miloradović Z, Mihailović-Stanojević N, Milanović JG, Ivanov M, Jerkić M, Jovović D.

Curr Pharm Biotechnol. 2011 Sep;12(9):1364-7. Review.

PMID:
21554222
19.

Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in Endoglin heterozygous mice.

Jerkic M, Peter M, Ardelean D, Fine M, Konerding MA, Letarte M.

Inflamm Bowel Dis. 2010 Nov;16(11):1859-70. doi: 10.1002/ibd.21288.

20.

Targeted genomic disruption of h-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism.

Chamorro-Jorganes A, Grande MT, Herranz B, Jerkic M, Griera M, Gonzalez-Nuñez M, Santos E, Rodriguez-Puyol D, Lopez-Novoa JM, Rodriguez-Puyol M.

Hypertension. 2010 Sep;56(3):484-9. doi: 10.1161/HYPERTENSIONAHA.110.152587. Epub 2010 Aug 2.

PMID:
20679183
21.

Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia.

Toporsian M, Jerkic M, Zhou YQ, Kabir MG, Yu LX, McIntyre BA, Davis A, Wang YJ, Stewart DJ, Belik J, Husain M, Henkelman M, Letarte M.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):509-17. doi: 10.1161/ATVBAHA.109.200121. Epub 2009 Dec 30.

PMID:
20042709
22.

Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice.

Belik J, Jerkic M, McIntyre BA, Pan J, Leen J, Yu LX, Henkelman RM, Toporsian M, Letarte M.

Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1170-8. doi: 10.1152/ajplung.00168.2009. Epub 2009 Oct 9.

23.

Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan.

Mihailovic-Stanojevic N, Jovovic D, Miloradovic Z, Grujic-Milanovic J, Jerkic M, Markovic-Lipkovski J.

Nephrol Dial Transplant. 2009 Apr;24(4):1142-50. doi: 10.1093/ndt/gfn596. Epub 2008 Nov 5.

PMID:
18987260
24.

Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade.

Miloradović Z, Jerkić M, Jovović D, Mihailović-Stanojević N, Milanović JG, Stosić G, Marković-Lipkovski J.

Nephrol Dial Transplant. 2007 Sep;22(9):2476-84. Epub 2007 Jun 2.

PMID:
17545678
25.

Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice.

Sauzeau V, Jerkic M, López-Novoa JM, Bustelo XR.

Mol Biol Cell. 2007 Mar;18(3):943-52. Epub 2007 Jan 3.

26.

Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice.

Düwel A, Eleno N, Jerkic M, Arevalo M, Bolaños JP, Bernabeu C, López-Novoa JM.

Tumour Biol. 2007;28(1):1-8. Epub 2006 Nov 14.

PMID:
17108712
27.

Endoglin regulates cyclooxygenase-2 expression and activity.

Jerkic M, Rivas-Elena JV, Santibanez JF, Prieto M, Rodríguez-Barbero A, Perez-Barriocanal F, Pericacho M, Arévalo M, Vary CP, Letarte M, Bernabeu C, López-Novoa JM.

Circ Res. 2006 Aug 4;99(3):248-56. Epub 2006 Jul 13.

28.

Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production.

Pérez-Rivero G, Ruiz-Torres MP, Rivas-Elena JV, Jerkic M, Díez-Marques ML, Lopez-Novoa JM, Blasco MA, Rodríguez-Puyol D.

Circulation. 2006 Jul 25;114(4):309-17. Epub 2006 Jul 10.

PMID:
16831983
29.

Reduced angiogenic responses in adult Endoglin heterozygous mice.

Jerkic M, Rodríguez-Barbero A, Prieto M, Toporsian M, Pericacho M, Rivas-Elena JV, Obreo J, Wang A, Pérez-Barriocanal F, Arévalo M, Bernabéu C, Letarte M, López-Novoa JM.

Cardiovasc Res. 2006 Mar 1;69(4):845-54. Epub 2006 Jan 10.

30.

Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats.

Morales AI, Vicente-Sánchez C, Jerkic M, Santiago JM, Sánchez-González PD, Pérez-Barriocanal F, López-Novoa JM.

Toxicol Appl Pharmacol. 2006 Jan 1;210(1-2):128-35. Epub 2005 Oct 14.

PMID:
16226777
31.

[Aging and hypertension as factors of progressive renal failure].

Mihailović-Stanojević N, Varagić J, Jovović D, Miloradović Z, Marković-Lipkovski J, Jerkić M.

Med Pregl. 2003;56 Suppl 1:59-64. Serbian.

PMID:
15510916
32.

Endoglin regulates nitric oxide-dependent vasodilatation.

Jerkic M, Rivas-Elena JV, Prieto M, Carrón R, Sanz-Rodríguez F, Pérez-Barriocanal F, Rodríguez-Barbero A, Bernabéu C, López-Novoa JM.

FASEB J. 2004 Mar;18(3):609-11. Epub 2004 Jan 20.

PMID:
14734648
33.

Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure.

Jerkić M, Miloradović Z, Jovović D, Mihailović-Stanojević N, Elena JV, Nastić-Mirić D, Grujić-Adanja G, Rodríguez-Barbero A, Marković-Lipkovski J, Vojvodić SB, Manero MV, Prieto MP, López-Novoa JM.

Nephrol Dial Transplant. 2004 Jan;19(1):83-94.

PMID:
14671043
34.

The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction.

Jerkić M, Vojvodić S, López-Novoa JM.

Int Urol Nephrol. 2001;32(4):539-47. Review.

PMID:
11989542
35.

Endoglin expression in human and rat mesangial cells and its upregulation by TGF-beta1.

Rodríguez-Barbero A, Obreo J, Eleno N, Rodríguez-Peña A, Düwel A, Jerkic M, Sánchez-Rodríguez A, Bernabéu C, López-Novoa JM.

Biochem Biophys Res Commun. 2001 Mar 23;282(1):142-7.

PMID:
11263983
36.

Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats.

Varagic J, Jerkic M, Jovovic D, Nastic-Miric D, Adanja-Grujic G, Markovic-Lipkovski J, Lackovic V, Radujkovic-Kuburovic G, Kentera D.

Am J Med Sci. 2000 Sep;320(3):171-6.

PMID:
11014370
37.

L-arginine reduces tubular cell injury in acute post-ischaemic renal failure.

Jerkić M, Varagić J, Jovović D, Radujković-Kuburović G, Nastić-Mirić D, Adanja-Grujić G, Marković-Lipkovski J, Dimitrijević J, Miloradović Z, Vojvodić SB.

Nephrol Dial Transplant. 1999 Jun;14(6):1398-407.

PMID:
10382999
38.

Factors affecting the ability of the renal medulla to exert an antihypertensive function.

Susić D, Radujković-Kuburović G, Jerkić M, Jovović D, Varagić J, Vukobratović S, Veljković V.

Indian J Med Res. 1995 Aug;102:81-5.

PMID:
8834819
39.

Megakaryocytopoiesis in spontaneously hypertensive rats (SHR).

Basara N, Jerkić M, Susić D, Pavlović-Kentera V.

Thromb Res. 1989 Mar 15;53(6):551-9.

PMID:
2734731
40.

Erythrocytosis in spontaneously hypertensive rats.

Pavlović-Kentera V, Basara N, Jerkić M, Biljanović-Paunović L, Clemons GK, Milenković P, Susić D.

Exp Hematol. 1988 Dec;16(11):950-3.

PMID:
3181346

Supplemental Content

Loading ...
Support Center